Gastrointestinal stromal tumor
Gastrointestinal stromal tumor (GIST) is a type of tumor that occurs in the gastrointestinal tract, specifically in the stomach and small intestine. GISTs are rare, but they are the most common mesenchymal neoplasms of the gastrointestinal tract. They originate from the interstitial cells of Cajal (ICC) or from stem cells that can differentiate into ICC.
Symptoms
The symptoms of GIST vary depending on the size and location of the tumor. Some people with GIST have no symptoms, and the tumor is discovered incidentally during an examination or procedure for another condition. When symptoms do occur, they may include abdominal pain, nausea, vomiting, bleeding in the digestive tract, anemia, and a mass in the abdomen.
Diagnosis
Diagnosis of GIST typically involves a combination of medical history, physical examination, imaging studies, and biopsy. Imaging studies such as computed tomography (CT) scan, magnetic resonance imaging (MRI), and positron emission tomography (PET) scan can help to identify the location and size of the tumor. Biopsy, in which a sample of the tumor is removed for examination under a microscope, is used to confirm the diagnosis.
Treatment
Treatment for GIST depends on the size, location, and aggressiveness of the tumor, as well as the patient's overall health. Options may include surgery, targeted therapy, radiation therapy, and chemotherapy. Surgery is the primary treatment for localized GIST. Targeted therapy with drugs such as imatinib (Gleevec) and sunitinib (Sutent) is used for advanced or metastatic GIST.
Prognosis
The prognosis for GIST varies widely depending on the size and location of the tumor, the patient's age and overall health, and the specific genetic mutations present in the tumor. In general, smaller tumors that are detected early and can be completely removed surgically have a better prognosis.
See also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


